FA
IDXX icon

Fiduciary Alliance’s Idexx Laboratories IDXX Stock Holding History

Fiduciary Alliance’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2
Closed -$1K – 514
2023
Q2 		$1K Buy
+2
New +$958 ﹤0.01% 861
2023
Q1 		– Sell
-2
Closed -$816 – 461
2022
Q4 		$816 Buy
+2
New +$776 ﹤0.01% 806

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Fiduciary Alliance's IDXX Position: Q3 2023 in Review

Fiduciary Alliance sold out of Idexx Laboratories (IDXX) in Q3 2023, closing a stake of 2 shares — an estimated $1K sold.

Fiduciary Alliance first reported a position in IDXX in Q4 2022 and held it in 2 quarters. The position peaked at $1K in Q2 2023. 1,059 funds tracked by Wall St. Rank hold IDXX as of Q3 2023.

  • Fiduciary Alliance reported no remaining Idexx Laboratories position as of Q3 2023 after selling out during the quarter.
  • Fiduciary Alliance sold 2 Idexx Laboratories shares in Q3 2023, an estimated $1K.
  • Fiduciary Alliance first reported a position in Idexx Laboratories in Q4 2022 and held it in 2 quarters.
  • Fiduciary Alliance's Idexx Laboratories position peaked at $1K in Q2 2023.
  • 1,059 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2023.

Based on Fiduciary Alliance's 13F filing for Q3 2023, filed 18 Oct 2023.